Literature DB >> 28673015

Preliminary asthma-related outcomes following glucagon-like peptide 1 agonist therapy.

F Khan1,2, A Mat3, A E Hogan3, B D Kent1, S Eigenheer1, M A Corrigan3, D O'Shea3,4, M W Butler1,2.   

Abstract

Year:  2017        PMID: 28673015     DOI: 10.1093/qjmed/hcx125

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


× No keyword cloud information.
  3 in total

Review 1.  Evaluating the glucagon-like peptide-1 receptor in managing asthma.

Authors:  Ashley Y Wu; Katherine N Cahill; Shinji Toki; R Stokes Peebles
Journal:  Curr Opin Allergy Clin Immunol       Date:  2022-02-01

2.  Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes.

Authors:  David Watchorn; Donal O'Shea; Marcus W Butler
Journal:  Am J Respir Crit Care Med       Date:  2021-04-01       Impact factor: 21.405

Review 3.  Dysregulated Metabolism in the Pathophysiology of Non-Allergic Obese Asthma.

Authors:  Matthew McCravy; Jennifer L Ingram; Loretta G Que
Journal:  J Asthma Allergy       Date:  2021-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.